Use of apoptosis-specific EIF-5A sirnas for the manufacture of a medicament for use in the treatment of a disease treatable by suppression of the JAK/STAT pathway

Disclosed is the use of an siRNA of an apoptosis specific eIF-5A in the manufacture of a medicament for use in the treatment of a condition treatable by suppression of the activation of the JAAK/STAT pathway, wherein said siRNA suppresses activation of the JAK/STAT pathway in a cell.

Saved in:
Bibliographic Details
Main Authors REZNIKOV, LEONID, THOMPSON, JOHN E, TAYLOR, CATHERINE, GALTON, BRUCE C, DINARELLO, CHARLES, HOPKINS, MARIANNE, BOONE, ADRIENNE
Format Patent
LanguageEnglish
Published 27.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is the use of an siRNA of an apoptosis specific eIF-5A in the manufacture of a medicament for use in the treatment of a condition treatable by suppression of the activation of the JAAK/STAT pathway, wherein said siRNA suppresses activation of the JAK/STAT pathway in a cell.
Bibliography:Application Number: NZ20050552692